title: Safety considerations of recombinant protein therapy: introductory comments.
authors.affiliation: Hoffmann-La Roche Inc., Nutley, New Jersey 07110-1199, USA.
authors.forename: T J
authors.initials: TJ
authors.lastname: Hayes
authors.forename: B
authors.initials: B
authors.lastname: Ryffel
mesh_terms: D000818:Animals; D000917:Antibody Formation; D006801:Humans; D007377:Interleukin-3 / Q000276:immunology; D011994:Recombinant Proteins / Q000592:standards* / Q000627:therapeutic use*
chemical_list: D007377:Interleukin-3; D011994:Recombinant Proteins